Clinical Trial Update: Clinical Study on the Safety and Efficacy of CD19-BCMA CAR-T Cell Therapy for Connective Tissue Diseases [NA]

View source ↗

Summary

A clinical trial is evaluating the safety and efficacy of CD19-BCMA CAR-T cell therapy for connective tissue diseases and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Connective Tissue Diseases

Drugs mentioned

• CD19/BCMA CAR-T Cell Therapy

Snippet

Sponsor: Guangzhou Bio-gene Technology Co., Ltd | Conditions: Connective Tissue Diseases | NA | Status: RECRUITING